I agree @zecs, killing bacteria that is on skin cells, separated from the body and blood and immune support is a far cry from proven human efficacy. Every single drug ever made that went to clinical trial would have first showed success in a test tube. How many made it through humam trials?
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-11
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.035(6.86%) |
Mkt cap ! $126.2M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 55.0¢ | 51.0¢ | $167.8K | 316.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 317 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 4099 | 2 |
View Market Depth
| Last trade - 15.59pm 06/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |